美迪西：股东林长青累计减持约154万股，减持计划时间区间届满

Group 1 - The core point of the news is that Medisi has announced the completion of a share reduction plan by shareholder Lin Changqing, who has reduced his holdings by approximately 1.15% of the company's total shares, totaling around 1.54 million shares [1] - As of the latest report, Medisi's market capitalization stands at 9.2 billion yuan [3] - The company's revenue composition for the year 2024 indicates that the preclinical CRO business accounts for 99.96% of total revenue, while other businesses contribute only 0.04% [2]